Microsynth AG

Microsynth (founded in 1989) is a leading company in Europe in the field of DNA/RNA syntheses & analyses. The main activities are divided into the following three business areas: 1. DNA/RNA SYNTHESES ›DNA/RNA oligonucleotides (unmodified, modified, various purity grades) for various R&D applications › Primers and probes (e.g. OEM kit production) for molecular diagnostics › antisense oligonucleotides as well as siRNAs for drug discovery 2. DNA/RNA ANALYSES AND SEQUENCING › DNA Sanger sequencing of all types (incl. GMP sequencing) › Next generation sequencing (de novo & re-sequencing at the genome level, RNA-Seq, metagenome and amplicon sequencing, bioinformatics, etc.) › PCR, qPCR and digital PCR › Genotyping (fragment length analysis, cell line characterization, STR marker development, GBS) › DNA/RNA isolations (all sources, including high-throughput format) 3. CONTRACT RESEARCH/OUTSOURCING › Assay establishment & validation (e.g. IVD, animal and food diagnostics) › Biological testing (e.g. lot release mRNA vaccines) › Gene editing/gene therapy (e.g. CRISPR on/off target GxP analyses, rAAV characterization) Microsynth employs >100 people and has branch offices in Germany (Microsynth Seqlab), France (Microsynth France), Austria (Microsynth Austria) and Switzerland (ecogenics). Microsynth is ISO 9001:2015-, ISO 13485:2016- (oligonucleotide synthesis, kit production), ISO/IEC 17025:2017 (STS 0429) - (NGS, Sanger sequencing, fragment length analysis) and GMP certified (Sanger sequencing). We’re truly proud to be a pillar of scientific progress in pharma, biotech, and medicine. Since being founded in 1989, we’ve been incredibly passionate about the synthesis and analysis of nucleic acids - whether it is for basic research, diagnostic, or therapeutic applications. We act quickly and we’re easy to do business with, and we always show respect for the environment in everything we do.